Article
A predictive assay for chemotherapeutic efficacy of stage IV colorectal cancer using serum metabolic features profiling
2024-03-19
Abstract excerpt
<h4>Background: </h4> Currently, there is no unbiased colorectal cancer (CRC) prognostic and predictive model based on serum molecular biomarkers to evaluate potential treatment outcomes and risk of CRC relapse for stage IV CRC patients. In addition, criteria to identify likely CRC patient populations at high risk and might benefit from additional chemotherapeutics have not yet been investigated, and it is an unme...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 76a6d8dc-7fdc-5b6f-b0f0-6f83603213e8
- DOI
- 10.21203/rs.3.rs-4104167/v1
